Lilly invites candidates to endorse a Europe that invests in health and biomedical advances. To welcome innovation, a single conversation is needed, that joins up industrial policy for growth and considers true value of medicines. We call for policies and pragmatic solutions to accelerate access to innovative medicines, improving health outcomes and health system sustainability, and to make Europe a globally competitive hub for the biopharmaceutical industry. Read the full text, by clicking on the pdf link below.